Loading...
Dernières publications
-
-
-
Hélène Bricout, Marie‐cécile Levant, Nada Assi, Pascal Crepey, Alexandre Descamps, et al.. The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021-22 influenza season. Clinical Microbiology and Infection, 2024, 30 (12), pp.1592-1598. ⟨10.1016/j.cmi.2024.08.012⟩. ⟨hal-04698967⟩
-
Mathieu Chalouni, Paul Loubet, Edouard Lhomme, Laetitia Ninove, Benoit Barrou, et al.. Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants. BMC Infectious Diseases, 2024, 24 (1), pp.1049. ⟨10.1186/s12879-024-09861-5⟩. ⟨hal-04724620⟩
-
Christine Durier, Laetitia Ninove, Sylvie van der Werf, Maeva Lefebvre, Corinne Desaint, et al.. Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination. Infectious Diseases Now, 2024, 54 (5), pp.104886. ⟨10.1016/j.idnow.2024.104886⟩. ⟨hal-04596145⟩
Le CIC-1417 sur Twitter
Documents en texte intégral
95
Notices
62
Mots clés
Vaccine acceptance
ANTIRETROVIRAL THERAPY
AON
Respiratory syncytial virus
Adult
Attitudes
Attitude to health
Conjugate pneumococcal vaccine
Awareness
Biomarkers
Healthcare workers
Adverse effects
Adjuvant
Boys
Confidence
Clinical trials
Chronic kidney disease
Immunogenicity
Adults
Cystic fibrosis
Antiretroviral therapy
SARS-CoV-2
Vaccines
Antiviral
Europe
Sleep
Administrative claims
Bayes' theorem
Cancer
Vaccination
Vaccine safety and efficacy
Older adults
Booster response
Practices
Specific populations
Attitude toward vaccines
Acute kidney injury
Country income
Risk factors
Community-acquired AKI
Coadministration
Conditional marketing authorization
Trust
Immunocompromised
Virology
Attitudes of health personnel
Influenza vaccines
COCONEL cohort surveys
Effectiveness
Chemotherapy
Cohort study
Cohort studies
Covid 19
Epidemiology
Adenoviral vector
Coronavirus
Antiviral agents
Assay
Clinical research
Calcium phosphorus evaluation
COVID-19 vaccines
Attitude
AstraZeneca vaccine
Clinical practice
Vaccine effectiveness
B-lymphocytes
Vaccine hesitancy
Hospitalisations
AIDS
Alpha variant
Antiviral therapy
Cohort
Influenza
Vaccine
Incidence
C-type lectin receptor
CERVICOVAGINAL SECRETIONS
Clinical skills
Internet
HIV
Efficacy
Elderly
Innate immunity
Misinformation
Immunization
1790GAHB F
Co-morbidities
Dialysis
Care management
HPV vaccine
France
Catch-up
COVID-19
Influenza-like illness
COVID-19 mRNA vaccine
Covid-19
Breakthrough infections
Cost of illness
Determinants
Hesitancy